Literature DB >> 20517696

Correlations between both the expression levels of inflammatory mediators and growth factor in medial perimeniscal synovial tissue and the severity of medial knee osteoarthritis.

Liang Ning1, Muneaki Ishijima, Haruka Kaneko, Hidetake Kurihara, Eri Arikawa-Hirasawa, Mitsuaki Kubota, Lizu Liu, Zhuo Xu, Ippei Futami, Anwarjan Yusup, Katsumi Miyahara, Shouyu Xu, Kazuo Kaneko, Hisashi Kurosawa.   

Abstract

An enhanced expression of the inflammatory mediators in the perimeniscal synovium in knee osteoarthritis (OA) has been suggested to contribute to progressive cartilage degeneration. However, whether the expression levels of these molecules correlated with the severity of OA still remained unclear. Medial perimeniscal synovial samples were obtained from 23 patients with Kellgren-Lawrence (K/L) grades 2 to 4 of medial knee OA. Immunohistochemical analysis of the synovium revealed that the MMP-1, COX-2 and IL-1β expression of the patients with K/L 4 to be significantly reduced in comparison to those with either K/L 2 or 3, while the TGF-β expression showed the opposite. The synovial expression of MMP-1 and IL-1β showed a significant negative correlation with the severity of OA, while that of TGF-β again showed the opposite. In conclusion, although synovial inflammation remained active, the MMP-1, COX-2 and IL-1β expression in synovium decreased depending upon the severity of OA, while the TGF-β expression increased.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20517696      PMCID: PMC3103960          DOI: 10.1007/s00264-010-1045-1

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  23 in total

1.  Inflammation in osteoarthritis.

Authors:  Steven B Abramson
Journal:  J Rheumatol Suppl       Date:  2004-04

Review 2.  Current concepts in the pathogenesis of osteoarthritis.

Authors:  S Krasnokutsky; M Attur; G Palmer; J Samuels; S B Abramson
Journal:  Osteoarthritis Cartilage       Date:  2008-08-23       Impact factor: 6.576

3.  Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial.

Authors:  Takayuki Kawasaki; Hisashi Kurosawa; Hiroshi Ikeda; Sung-Gon Kim; Aki Osawa; Yuji Takazawa; Mitsuaki Kubota; Muneaki Ishijima
Journal:  J Bone Miner Metab       Date:  2008-05-11       Impact factor: 2.626

4.  Immunohistological features in the synovium obtained from clinically uninvolved knee joints of patients with rheumatoid arthritis.

Authors:  M Soden; M Rooney; A Cullen; A Whelan; C Feighery; B Bresnihan
Journal:  Br J Rheumatol       Date:  1989-08

5.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

Authors:  R Altman; E Asch; D Bloch; G Bole; D Borenstein; K Brandt; W Christy; T D Cooke; R Greenwald; M Hochberg
Journal:  Arthritis Rheum       Date:  1986-08

6.  Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis.

Authors:  A I Catrina; J Lampa; S Ernestam; E af Klint; J Bratt; L Klareskog; A-K Ulfgren
Journal:  Rheumatology (Oxford)       Date:  2002-05       Impact factor: 7.580

7.  Computerized quantification of tissue vascularization using high-resolution slide scanning of whole tumor sections.

Authors:  Christophe F Chantrain; Yves A DeClerck; Susan Groshen; George McNamara
Journal:  J Histochem Cytochem       Date:  2003-02       Impact factor: 2.479

8.  Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation.

Authors:  P L E M van Lent; A B Blom; P van der Kraan; A E M Holthuysen; E Vitters; N van Rooijen; R L Smeets; K C A M Nabbe; W B van den Berg
Journal:  Arthritis Rheum       Date:  2004-01

9.  Histological analysis of synovium in cases of effect attenuation associated with infliximab therapy in rheumatoid arthritis.

Authors:  Katsuaki Kanbe; Kazuhiko Inoue; Yasuo Inoue; Yutaka Suzuki
Journal:  Clin Rheumatol       Date:  2008-02-07       Impact factor: 2.980

Review 10.  Developments in the scientific understanding of osteoarthritis.

Authors:  Steven B Abramson; Mukundan Attur
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more
  17 in total

1.  Thirty days after anterior cruciate ligament transection is sufficient to induce signs of knee osteoarthritis in rats: pain, functional impairment, and synovial inflammation.

Authors:  Germanna M Barbosa; Jonathan E Cunha; Thiago L Russo; Thiago M Cunha; Paula A T S Castro; Francisco F B Oliveira; Fernando Q Cunha; Fernando S Ramalho; Tania F Salvini
Journal:  Inflamm Res       Date:  2020-01-31       Impact factor: 4.575

Review 2.  The evolving role of biomarkers for osteoarthritis.

Authors:  Muneaki Ishijima; Haruka Kaneko; Kazuo Kaneko
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-08       Impact factor: 5.346

Review 3.  Cytokines as biochemical markers for knee osteoarthritis.

Authors:  Thomas Mabey; Sittisak Honsawek
Journal:  World J Orthop       Date:  2015-01-18

4.  Increased apelin serum levels and expression in human chondrocytes in osteoarthritic patients.

Authors:  Peng-fei Hu; Jing-li Tang; Wei-ping Chen; Jia-peng Bao; Li-dong Wu
Journal:  Int Orthop       Date:  2010-07-22       Impact factor: 3.075

5.  Serum interleukin 6 levels are associated with depressive state of the patients with knee osteoarthritis irrespective of disease severity.

Authors:  Yukio Shimura; Hisashi Kurosawa; Masaru Tsuchiya; Mamiko Sawa; Haruka Kaneko; Lizu Liu; Yuji Makino; Hidetoshi Nojiri; Yoshiyuki Iwase; Kazuo Kaneko; Muneaki Ishijima
Journal:  Clin Rheumatol       Date:  2017-09-12       Impact factor: 2.980

6.  Synovial perlecan is required for osteophyte formation in knee osteoarthritis.

Authors:  Haruka Kaneko; Muneaki Ishijima; Ippei Futami; Naoki Tomikawa-Ichikawa; Keisuke Kosaki; Ryo Sadatsuki; Yoshihiko Yamada; Hisashi Kurosawa; Kazuo Kaneko; Eri Arikawa-Hirasawa
Journal:  Matrix Biol       Date:  2013-01-20       Impact factor: 11.583

7.  Profiling the secretion of soluble mediators by end stage osteoarthritis synovial tissue explants reveals a reduced responsiveness to an inflammatory trigger.

Authors:  Lobke M Gierman; Benno van El; Frits van der Ham; Angela Koudijs; Reinout Stoop; Jan H Verheijen; Margreet Kloppenburg; Gerjo J V M van Osch; Vedrana Stojanovic-Susulic; Tom W J Huizinga; Anne-Marie Zuurmond
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

8.  Joint inflammation and early degeneration induced by high-force reaching are attenuated by ibuprofen in an animal model of work-related musculoskeletal disorder.

Authors:  Jeffrey B Driban; Ann E Barr; Mamta Amin; Michael R Sitler; Mary F Barbe
Journal:  J Biomed Biotechnol       Date:  2011-03-03

9.  The E3 ubiquitin ligase Itch limits the progression of post-traumatic osteoarthritis in mice by inhibiting macrophage polarization.

Authors:  X Lin; W Wang; A McDavid; H Xu; B F Boyce; L Xing
Journal:  Osteoarthritis Cartilage       Date:  2021-04-30       Impact factor: 7.507

10.  Intra-articular hyaluronic acid injection versus oral non-steroidal anti-inflammatory drug for the treatment of knee osteoarthritis: a multi-center, randomized, open-label, non-inferiority trial.

Authors:  Muneaki Ishijima; Toshitaka Nakamura; Katsuji Shimizu; Kunihiko Hayashi; Hiraku Kikuchi; Satoshi Soen; Go Omori; Toshihiko Yamashita; Yuji Uchio; Junji Chiba; Yuki Ideno; Mitsuaki Kubota; Hisashi Kurosawa; Kazuo Kaneko
Journal:  Arthritis Res Ther       Date:  2014-01-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.